Work

Economic analysis of the phase III MENSA study evaluating mepolizumab for severe asthma with eosinophilic phenotype

Year: 2017

Type: article

Source: Expert Review of Pharmacoeconomics & Outcomes Research

DOI: 10.1080/14737167.2017.1298444

Authors: Anirban Basu, Anand Dalal, Giorgio Walter Canonica, Mark Forshag, Steven W. Yancey, Saurabh Nagar, Christopher F. Bell

Institutions: University of Washington, GlaxoSmithKline (United States), Humanitas University, IRCCS Humanitas Research Hospital, RTI Health Solutions

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: GlaxoSmithKline

OpenAlex ID: W2597189406

FWCI: 1.624

Cites: 35

Cited by: 18

Related to: 10